Brief: Medicalgorithmics Adopts Growth Strategy For 2023-2026

Medicalgorithmics SA

20/06/2023 07:07

June 20 (Reuters) - Medicalgorithmics SA  MDG.WA :
    * SAID ON MONDAY IT HAS ADOPTED GROWTH STRATEGY FOR
2023-2026
    * UNDER STRATEGY COMPANY TO SEPARATE SOFTWARE FROM EQUIPMENT
    * TO MONETISE THE SOFTWARE THAT IT ALREADY OWNS (PC CLIENT
SOFTWARE) AND AI(DRAI) 
    * TO IMPLEMENT SALES STRATEGY BASED ON HARDWARE INDEPENDENCE
    * IN ORDER TO START ITS GROWTH THE COMPANY HAS TERMINATED
THE
EXCLUSIVITY AGREEMENT WITH ITS CURRENT PARTNER IN THE US, WHICH
MAY RESULT IN REVENUE DECREASE IN 2023 COMPARED TO 2022 
    * HOWEVER THE COMPANY PLANS TO ACQUIRE NEW DISTRIBUTORS 
    * IT WILL CONTINUE SALES OF POCKET ECG AND INTEGRATED
HARDWARE
SOLUTIONS ON MARKETS WHERE IT DOES NOT COMPETE WITH ITS NEW
CLIENTS  
    * UNDER STRATEGY IT WILL ALSO CARRY OUT SCIENTIFIC RESEARCH
SUPPORTING DEVELOPMENT OF STATE-OF-THE-ART MEDICAL TECHNOLOGIES
    * IT WILL CREATE VALUE THROUGH ORGANIC GROWTH AND VALUABLE
TECHNOLOGICAL AND BUSINESS PARTNERSHIPS, ALSO IN FORM OF MERGERS
AND TAKEOVERS 
    * THE COMPANY HAS RESOURCES FOR IMPLEMENTATION OF STRATEGIC
GOALS
TILL 2026 (39 MLN ZLOTYS)

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM2TGxWHa
 Further company coverage:  MDG.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))